$KO Headlines Buffett talks up IBM and Pepsi, dismisses

New Post Public Reply Private Reply Replies (0) Message Board

Mar 4, 2014 at 11:17 AM

$KO Headlines

Buffett talks up IBM and Pepsi, dismisses bitcoin 12:48 p.m. March 3, 2014 - Ben Eisen
Target, J.C. Penney, SodaStream are stocks to watch 5:30 a.m. Feb. 26, 2014 - Sue Chang
The world's largest hedge fund’s latest moves 11:46 a.m. Feb. 24, 2014 - Insider Monkey
Latest moves of David Winters’ Wintergreen Advisers 11:41 a.m. Feb. 24, 2014 - Insider Monkey
U.S. stock futures trim losses after data 8:58 a.m. Feb. 19, 2014 - Sara Sjolin
Newscast: Nasdaq extends its winning streak 6:56 p.m. Feb. 18, 2014 - MarketWatch
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Newscast: Coca-Cola sales fall flat 4:29 p.m. Feb. 18, 2014 - MarketWatch
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Newscast: Coke stock is ice cold 2:23 p.m. Feb. 18, 2014 - MarketWatch
Why Coke needs Green Mountain 1:15 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Newscast: Food fight among tuna makers 12:39 p.m. Feb. 18, 2014 - MarketWatch
Newscast: Wall Street resumes gains 9:59 a.m. Feb. 18, 2014 - MarketWatch
Coca-Cola down 2.9%, top DJIA loser 9:34 a.m. Feb. 18, 2014 - William L. Watts
U.S. stock futures trim rise; Forest Labs soars 9:14 a.m. Feb. 18, 2014 - Sara Sjolin
Coca-Cola’s profit, revenue fall 8:19 a.m. Feb. 18, 2014 - Michael Calia
Coca-Cola profit falls in fourth quarter 7:49 a.m. Feb. 18, 2014 - Ben Eisen
Coca-Cola reports Q4 global volume growth of 1% 7:38 a.m. Feb. 18, 2014 - Ben Eisen
Coca-Cola targets $2.5 bln-$3 bln in 2014 buybacks 7:37 a.m. Feb. 18, 2014 - Ben Eisen

Scouting For New Dividend Ideas 8:37 a.m. Today - Seeking Alpha
Analysts' Actions: ANF CLX KO PG PHM 8:31 a.m. Today - TheStreet.com
Dividend Stocks Vs. Dividend ETFs 8:13 a.m. Today - Seeking Alpha
SodaStream: Time to Go Long This Short Favorite? 7:58 a.m. Today - Barrons.com
Why UBS Gave Coca-Cola (KO) a "Neutral" Rating 7:55 a.m. Today - TheStreet.com
Top Analyst Upgrades and Downgrades: Cliffs, Dendreon, Magna, Santander, SunEdison and More 7:31 a.m. Today - 247WallSt.com
SodaStream - Bubbling To The Top Of Your Portfolio 4:26 a.m. Today - Seeking Alpha
How To Generate An 11% Yield On Cost In 6 Years 12:47 a.m. Today - Seeking Alpha
Green Mountain-Laura Secord Sign Deal - Analyst Blog 6:55 p.m. March 3, 2014 - Zacks.com
Coca-Cola and Kinder Morgan Report Big CEO Buys Over the Past Week 5:21 p.m. March 3, 2014 - GuruFocus.com
Guru Stocks at 52-Week Lows: CHL, KO, T, PBR, EC 5:10 p.m. March 3, 2014 - GuruFocus.com
Weekly CEO Buys Highlight: KMI, CLMS, RTRX, OPK, KO 4:57 p.m. March 3, 2014 - GuruFocus.com
Ukraine Tensions Hit Global Companies 4:02 p.m. March 3, 2014 - WSJ.com
Ukraine Tensions Hit Global Companies 4:02 p.m. March 3, 2014 - The Wall Street Journal Interactive Edition
Warren Buffett's 10 Favorite Dividend Stocks 3:35 p.m. March 3, 2014 - TheStreet.com
Warren Buffett on Railroads, Top Holdings Sales Plans, Future Acquisitions, Will Plans 2:23 p.m. March 3, 2014 - GuruFocus.com
Russia a Popular Market for U.S. Companies 2:16 p.m. March 3, 2014 - FOXBusiness
Peltz/Pepsi Fight for Split Continues - Analyst Blog 2:10 p.m. March 3, 2014 - Zacks.com
ModernGraham Annual Valuation Of Coca-Cola Company 1:23 p.m. March 3, 2014 - Seeking Alpha
SodaStream Falls On Competition Despite SunnyD Deal 12:02 p.m. March 3, 2014 - Investors Business Daily

Critical Alerts For Coca Cola, News Corp, MGM, First Solar, and Ciena Released By InvestorsObserver 9:31 a.m. March 3, 2014 - PR Newswire - PRF
Green Mountain Coffee Roasters and The Coca-Cola Company Close on Previously Announced Equity Transaction 11:00 a.m. Feb. 27, 2014 - BusinessWire - BZX
Diet Coke® Launches Diet Coke FROST – First Frozen Product Offering in Brand’s History 9:02 a.m. Feb. 26, 2014 - BusinessWire - BZX
Consensus Earnings Forecast for BlackBerry, AT&T, Micron, InterMune, RF Micro Devices, and Coca-Cola 9:00 a.m. Feb. 26, 2014 - PR Newswire - PRF
Coke ZeroTM Renews Agreement with CIAA® and Reinforces Commitment to Education 12:01 p.m. Feb. 25, 2014 - BusinessWire - BZX
The Coca-Cola Company Announces Letters of Intent with Two New Bottling Partners 8:00 a.m. Feb. 21, 2014 - BusinessWire - BZX
The Coca-Cola Company Chief Financial Officer Gary P. Fayard to Retire 1:43 p.m. Feb. 20, 2014 - BusinessWire - BZX
Donald F. McHenry, Jacob Wallenberg to Retire from The Coca-Cola Company Board of Directors 12:37 p.m. Feb. 20, 2014 - BusinessWire - BZX
The Board of Directors of The Coca-Cola Company Announces 52nd Consecutive Annual Dividend Increase 10:30 a.m. Feb. 20, 2014 - BusinessWire - BZX
Coca-Cola earnings disappoint and Tesla shares hit new high on Apple Rumor 12:32 a.m. Feb. 19, 2014 - ACCESSWIRE
The Coca-Cola Company Reports Full-Year and Fourth Quarter 2013 Results 7:30 a.m. Feb. 18, 2014 - BusinessWire - BZX
Coca-Cola® Brings Stellar Line up to Calle Ocho 2014 3:01 p.m. Feb. 13, 2014 - BusinessWire - BZX
The Coca-Cola Company to Present at Consumer Analyst Group of Europe Conference 9:00 a.m. Feb. 10, 2014 - BusinessWire - BZX
Rise and Shine the Whole Day with Minute Maid® Drops™ 1:02 p.m. Feb. 6, 2014 - BusinessWire - BZX
eResearch Posts Technical Comments on FM Final Trade for February 5 11:25 a.m. Feb. 6, 2014 - ACCESSWIRE
The Coca-Cola Company and Green Mountain Coffee Roasters, Inc. Enter into Long-Term Global Strategic Partnership 4:28 p.m. Feb. 5, 2014 - BusinessWire - BZX
Charleys and The Coca-Cola Company Announce New Product and Marketing Agreement 11:39 a.m. Feb. 5, 2014 - Marketwire
Coke Zero Dresses Up for Champion Seahawks 8:37 p.m. Feb. 4, 2014 - BusinessWire - BZX
Fiesta Restaurant Group®, Inc., Announces Multi-Year Marketing Agreement with The Coca-Cola Company 7:00 a.m. Feb. 4, 2014 - BusinessWire - BZX
TrendingWallStreet.com Begins Trending PVCT, ORMP, KO, and MCIG 12:27 a.m. Feb. 4, 2014 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...